Regulus Stock Surges on Positive Phase I HCV Data; Phase II on Deck for 2015


New Data Suggest Atypical microRNA Can Pass through the Gut, Stir Controversy


Two Studies Uncover New Non-RNAi Roles for Argonaute-1, Dicer


Alnylam Launches Screening Assistance Program for Genetic Diseases


Tekmira Begins Manufacture of Ebola Drug for Variant Involved in Outbreak


IP Update: Recent Patents Awarded to Devgen, Alnylam, Alcon, and More


Transgenomic Raises $2.4M in Private Placement


Researchers Sequence High-Quality Genome for 45,000-Year-Old Modern Human


Enigma Dx Inks Joint Venture, $50M Subscription Agreements


MDx Platform Firm InSilixa Completes $13M Financing Round